$ECOR
electroCore, Inc. Stock $ecor

$ecor Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000121390021040540 Filed on August 05, 2021

Income Statement

Concept	2021 Q3	2021 Q2	2020 Q2
Revenue	$1.487M	$1.269M	$753.0K
YoY Change	37.59%	68.54%	20.91%
Cost Of Revenue	$355.0K	$374.0K	$273.0K
YoY Change	2.17%	37.0%	7.29%
Gross Profit	$1.132M	$895.0K	$480.0K
YoY Change	54.37%	86.47%	30.32%
Gross Profit Margin	76.12%	70.53%	63.74%
Selling, General & Admin	$4.647M	$5.272M	$5.273M
YoY Change	1.17%	-0.03%	-43.83%
% of Gross Profit	410.48%	589.05%	1098.68%
Research & Development	$470.3K	$825.0K	$1.031M
YoY Change	-25.23%	-19.94%	-58.95%
% of Gross Profit	41.54%	92.18%	214.71%
Depreciation & Amortization	$95.11K	$91.34K	$90.00K
YoY Change	-4.89%	1.49%	252.64%
% of Gross Profit	8.4%	10.21%	18.75%
Operating Expenses	$5.117M	$6.097M	$6.403M
YoY Change	-2.01%	-4.79%	-46.18%
Operating Profit	-$3.985M	-$5.202M	-$5.923M
YoY Change	-11.22%	-12.18%	-52.15%
Interest Expense	$3.830K	$1.270K	$10.00K
YoY Change	7.16%	-87.3%	-96.43%
% of Operating Profit
Other Income/Expense, Net	$63.00	$1.423M	$11.08K
YoY Change	-97.13%	12745.28%	-96.03%
Pretax Income	-$3.985M	-$3.779M	-$5.912M
YoY Change	-11.18%	-36.08%	-51.14%
Income Tax	$8.705K	-$885.0K	-$1.171M
% Of Pretax Income
Net Earnings	-$3.994M	-$2.894M	-$4.742M
YoY Change	-10.98%	-38.96%	-60.82%
Net Earnings / Revenue	-268.56%	-228.05%	-629.72%
Basic Earnings Per Share	$0.06	-$0.06
Diluted Earnings Per Share	-$57.45K	-$59.64K	-$129.3K
COMMON SHARES
Basic Shares Outstanding	69.39M shares	48.52K shares	35.85M
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.00M	$23.73M	$18.90M
YoY Change	50.17%	25.54%	-54.05%
Cash & Equivalents	$38.00M	$14.70M	$14.86M
Short-Term Investments	$1.001M	$9.028M	$4.000M
Other Short-Term Assets	$1.476M	$235.7K	$200.0K
YoY Change	-13.16%	17.86%	-60.0%
Inventory	$1.082M	$1.078M	$800.0K
Prepaid Expenses
Receivables	$329.8K	$369.2K	$100.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$41.88M	$25.41M	$19.90M
YoY Change	46.45%	27.69%	-57.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$171.0K	$195.9K	$1.500M
YoY Change	-36.08%	-86.94%	275.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.975M	$685.9K	$7.200M
YoY Change	441.15%	-90.47%	449.51%
Total Long-Term Assets	$5.686M	$5.888M	$8.800M
YoY Change	-32.9%	-33.1%	160.7%
TOTAL ASSETS
Total Short-Term Assets	$41.88M	$25.41M	$19.90M
Total Long-Term Assets	$5.686M	$5.888M	$8.800M
Total Assets	$47.57M	$31.30M	$28.70M
YoY Change	28.31%	9.05%	-43.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.251M	$2.299M	$1.900M
YoY Change	-38.35%	20.99%	-16.28%
Accrued Expenses	$4.430M	$2.916M	$2.155M
YoY Change	74.68%	35.34%	-51.7%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$600.0K
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$5.739M	$5.757M	$5.076M
YoY Change	-1.25%	13.43%	-28.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$900.0K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$715.5K	$923.2K	$1.200M
YoY Change	-28.45%	-23.07%	-29.41%
Total Long-Term Liabilities	$715.5K	$923.2K	$2.100M
YoY Change	-68.89%	-56.04%	23.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.739M	$5.757M	$5.076M
Total Long-Term Liabilities	$715.5K	$923.2K	$2.100M
Total Liabilities	$6.454M	$6.681M	$7.116M
YoY Change	-21.09%	-6.11%	-19.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$119.3M	-$115.3M	-$96.18M
YoY Change	18.47%	19.85%	49.6%
Common Stock	$159.8M	$48.69K	$117.2M
YoY Change	353439.77%	-99.96%	11.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$40.48M	$23.98M	$20.91M
YoY Change
Total Liabilities & Shareholders Equity	$47.57M	$31.30M	$28.66M
YoY Change	28.31%	9.21%	-43.31%

Cashflow Statement

Concept	2021 Q3	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$3.994M	-$2.894M	-$4.742M
YoY Change	-10.98%	-38.96%	-60.82%
Depreciation, Depletion And Amortization	$95.11K	$91.34K	$90.00K
YoY Change	-4.89%	1.49%	252.64%
Cash From Operating Activities	-$3.447M	-$1.666M	-$3.910M
YoY Change	-25.22%	-57.39%	-65.46%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$8.000M	$7.297M	-$4.000M
YoY Change	-144.03%	-282.43%	-130.33%
Cash From Investing Activities	$8.000M	$7.297M	-$4.000M
YoY Change	-144.03%	-282.43%	-130.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	18.76M	350.0	7.260M
YoY Change	58.62%	-100.0%
NET CHANGE
Cash From Operating Activities	-3.447M	-1.666M	-3.910M
Cash From Investing Activities	8.000M	7.297M	-4.000M
Cash From Financing Activities	18.76M	350.0	7.260M
Net Change In Cash	23.32M	5.632M	-650.0K
YoY Change	-312.94%	-966.39%	-135.52%
FREE CASH FLOW
Cash From Operating Activities	-$3.447M	-$1.666M	-$3.910M
Capital Expenditures			$0.00
Free Cash Flow			-$3.910M
YoY Change			-65.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	City Area Code CityAreaCode	973
	dei	Local Phone Number LocalPhoneNumber	290-0097
	dei	Trading Symbol TradingSymbol	ECOR
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	69392030	shares
CY2021Q2	us-gaap	Cash Cash	14699111	USD
CY2020Q4	us-gaap	Cash Cash	4241937	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9027807	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	18386160	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	369189	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45559765	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Central Index Key EntityCentralIndexKey	0001560258
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Entity File Number EntityFileNumber	001-38538
	dei	Entity Registrant Name EntityRegistrantName	electroCore, Inc.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3454976
	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Forge Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 205
	dei	Entity Address City Or Town EntityAddressCityOrTown	Rockaway
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07866
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	270546	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	1077818	USD
	us-gaap	Restructuring Charges RestructuringCharges	464606	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	876436	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	235705	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1288588	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	25063667	USD
CY2021Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	4450569	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	4865181	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	195852	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	244047	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	555238	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517257	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	685894	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	828011	USD
CY2021Q2	us-gaap	Assets Assets	31297183	USD
CY2020Q4	us-gaap	Assets Assets	31518163	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2298721	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2078699	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2916080	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2800820	USD
CY2021Q2	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable		USD
CY2020Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	476236	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	534547	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5757496	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5890302	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	923181	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	885333	USD
CY2021Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1097946	USD
CY2021Q2	us-gaap	Liabilities Liabilities	6680677	USD
CY2020Q4	us-gaap	Liabilities Liabilities	7873581	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48690424	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48690424	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45559765	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	48690	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	45560	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	139302400	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	130205027	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115267732	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106990148	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-102462	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-251467	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	23980896	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	23008972	USD
CY2021Q2	us-gaap	Minority Interest MinorityInterest	635610	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	635610	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24616506	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31297183	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31518163	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1269464	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	752955	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2473308	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1486726	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	374271	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	272986	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23644582	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	738258	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	571101	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	895193	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	479969	USD
	us-gaap	Gross Profit GrossProfit	1735050	USD
	us-gaap	Gross Profit GrossProfit	915625	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	824906	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1030530	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1323871	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2553644	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5272921	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5273329	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10997509	USD
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges		USD
CY2020Q2	us-gaap	Restructuring Charges RestructuringCharges	99606	USD
	us-gaap	Restructuring Charges RestructuringCharges		USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	6097827	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	6403465	USD
	us-gaap	Operating Expenses OperatingExpenses	12321380	USD
	us-gaap	Operating Expenses OperatingExpenses	14852305	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5202634	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5923496	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10586330	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13936680	USD
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1422214	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1422214	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		USD
CY2021Q2	ecor	Interest And Others Income InterestAndOthersIncome	1273	USD
CY2020Q2	ecor	Interest And Others Income InterestAndOthersIncome	11765	USD
	ecor	Interest And Others Income InterestAndOthersIncome	1137	USD
	ecor	Interest And Others Income InterestAndOthersIncome	74741	USD
CY2021Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		USD
CY2020Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	687	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	9828	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1423487	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11078	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1423351	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	64913	USD
CY2021Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3779147	USD
CY2020Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5912418	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-9162979	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-13871767	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-885395	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48520241	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	36658797	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48089117	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33216512	shares
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2893752	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-4741528	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8277584	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1170890	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-885395	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1170890	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2893752	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-4741528	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8277584	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12700877	USD
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Net Income Loss NetIncomeLoss	-12700877	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5267	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-109337	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	146648	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-64015	USD
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-406	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-7059	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2357	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1233	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-116396	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	149005	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-65248	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2888891	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4857924	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8128579	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12766125	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23644582	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5383832	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	144144	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6920350	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		USD
CY2021Q1	ecor	Stock Issued During Period Value Settlement Of Accrued Bonus StockIssuedDuringPeriodValueSettlementOfAccruedBonus	399997	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	942183	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26667424	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2893752	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2893752	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	4861	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	837973	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24616506	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24897118	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-7959349	USD
CY2020Q1	ecor	Equity Financing Commitment Fee EquityFinancingCommitmentFee		USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	744865	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17733782	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-4741528	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-116396	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7831535	USD
CY2020Q2	ecor	Equity Financing Commitment Fee EquityFinancingCommitmentFee		USD
CY2020Q2	ecor	Financing Fees FinancingFees	167299	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1002758	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21542852	USD
	us-gaap	Profit Loss ProfitLoss	-8277584	USD
	us-gaap	Profit Loss ProfitLoss	-12700877	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1780156	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1747623	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	191342	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	193687	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-114404	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1396	USD
	ecor	Gains Loss On Extinguishment Of Debt GainsLossOnExtinguishmentOfDebt	1422214	USD
	ecor	Gains Loss On Extinguishment Of Debt GainsLossOnExtinguishmentOfDebt		USD
	ecor	Legal Expense Settled With Stock LegalExpenseSettledWithStock		USD
	ecor	Legal Expense Settled With Stock LegalExpenseSettledWithStock	156434	USD
	ecor	Noncash Lease Expense Net NoncashLeaseExpenseNet	40641	USD
	ecor	Noncash Lease Expense Net NoncashLeaseExpenseNet	178302	USD
	us-gaap	Inventory Write Down InventoryWriteDown	39478	USD
	us-gaap	Inventory Write Down InventoryWriteDown		USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense		USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-10058	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	98643	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-376654	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-173752	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	58286	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1081918	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-897481	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	220022	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1787364	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	363289	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1294684	USD
	ecor	Increase Decrease In Right Of Use Operating Leases IncreaseDecreaseInRightOfUseOperatingLeases	78622	USD
	ecor	Increase Decrease In Right Of Use Operating Leases IncreaseDecreaseInRightOfUseOperatingLeases		USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	45996	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-228572	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5826065	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12510940	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5082730	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3998604	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	14300000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	10500000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9217270	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6501396	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6920350	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5959101	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1410524	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6920350	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7369625	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	145619	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-60744	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10457174	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1299337	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4241937	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14699111	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14863128	USD
	ecor	Proceeds From Sale Of State Net Operating Losses ProceedsFromSaleOfStateNetOperatingLosses	1425395	USD
	ecor	Proceeds From Sale Of State Net Operating Losses ProceedsFromSaleOfStateNetOperatingLosses	1170890	USD
	us-gaap	Interest Paid Net InterestPaidNet		USD
	us-gaap	Interest Paid Net InterestPaidNet	5797	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4666	USD
	us-gaap	Stock Issued1 StockIssued1	399997	USD
	us-gaap	Stock Issued1 StockIssued1		USD
	ecor	Accounts Payable Paid Through Issuance Of Common Stock AccountsPayablePaidThroughIssuanceOfCommonStock		USD
	ecor	Accounts Payable Paid Through Issuance Of Common Stock AccountsPayablePaidThroughIssuanceOfCommonStock	1548702	USD
	ecor	Incurred Loss IncurredLoss	8300000	USD
	ecor	Incurred Loss IncurredLoss	12700000	USD
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	6900000	USD
CY2021Q2	ecor	Cashand Cash Equivalentsand Marketable Securities CashandCashEquivalentsandMarketableSecurities	23700000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-228572	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div id="t_ft_TFYWK222V400000000000000000000b"> <table cellpadding="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> (c) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> Use of Estimates </span></p> </td> </tr> </tbody> </table> </div> </div> </div> <p style="margin: 6pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">The preparation of financial statements in conformity with U.S.</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of these condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include allowances for doubtful accounts, trade credits, rebates, co-payment assistance and sales returns, valuation of inventory</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">, stock compensation, and contingencies.</span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div id="t_ft_RBNCVNO2E800000000000000000000b"> <table cellpadding="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> (d) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span><span style="font-weight: bold; font-style: italic;"> Reclass of Statement of Cash Flows Activity</span> </span></p> </td> </tr> </tbody> </table> </div> <p style="margin: 6pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">In order to reflect certain activity for the six months ended June 30, 2020 consistent with the June 30, 2021 presentation, this activity as <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">reflected in the accompanying Condensed Consolidated Statements of Cash Flows </span>was reclassed for presentation purposes only. The repayments of note payable of $111,878, included under the caption Cash flows from financing activities for the six months ended June 30, 2020 was reclassed to <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Net cash used in operating activities under the caption Accrued expense and other current liabilities with</span>in the accompanying <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Condensed Consolidated Statements of Cash Flows. Additionally, the decrease in operating lease liabilities of $228,572 previously included under the caption Net noncash lease expense for the six months ended June 30, 2020 was reclassed to Operating lease liabilities within the accompanying Condensed Consolidated Statements of Cash Flows. </span></span></p>
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	111878	USD
	ecor	Recent Accounting Pronouncements Not Yet Adopted RecentAccountingPronouncementsNotYetAdopted	<div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div id="t_ft_9K9RIT3CCW00000000000000000000b"> <table cellpadding="0" style="height: 0px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr> <td style="vertical-align: top; padding-left: 0px; padding-right: 0px; margin: 0px; text-indent: 0px; width: 3%;"> <p style="margin: 0px; padding-left: 0px; padding-right: 0px; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> (e) </span></p> </td> <td style="vertical-align: top; padding-left: 0px; padding-right: 0px; margin: 0px; text-indent: 0px; width: 97%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> Recent Accounting Standards Not Yet Adopted </span></p> </td> </tr> </tbody> </table> </div> </div> </div> <p style="margin: 6pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">In December 2019, the FASB issued an update to simplify the accounting for income taxes and improve consistent application by clarifying or amending existing guidance. This guidance is effective for the year ended December 31, 2021. The Company does not expect this guidance to have a material impact on its consolidated financial statements upon adoption.</span></p>
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1269464	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2473308	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1486726	USD
CY2021Q2	ecor	Maximum Amount Of Reduction In Monthly Co Payments Of Each Prescription MaximumAmountOfReductionInMonthlyCoPaymentsOfEachPrescription	100	USD
CY2021Q2	ecor	Cash And Cash Equivalents Amortized Cost CashAndCashEquivalentsAmortizedCost	14699111	USD
CY2021Q2	ecor	Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax		USD
CY2021Q2	ecor	Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax		USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14699111	USD
CY2021Q2	ecor	Cash And Cash Equivalents And Marketable Securities Amortized Cost Basis Current CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCostBasisCurrent	23727371	USD
CY2021Q2	ecor	Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Gains Before Tax Current CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedGainsBeforeTaxCurrent		USD
CY2021Q2	ecor	Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax Current CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent	453	USD
CY2021Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	23726918	USD
CY2020Q4	ecor	Cash And Cash Equivalents Amortized Cost CashAndCashEquivalentsAmortizedCost	4241937	USD
CY2020Q4	ecor	Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax		USD
CY2020Q4	ecor	Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax		USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4241937	USD
CY2020Q4	ecor	Cash And Cash Equivalents And Marketable Securities Amortized Cost Basis Current CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCostBasisCurrent	22630907	USD
CY2020Q4	ecor	Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Gains Before Tax Current CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedGainsBeforeTaxCurrent		USD
CY2020Q4	ecor	Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax Current CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent	2810	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	22628097	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	14699111	USD
CY2021Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	23726918	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4241937	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	22628097	USD
CY2021Q2	ecor	Inventory Raw Materials Current And Noncurrent InventoryRawMaterialsCurrentAndNoncurrent	867096	USD
CY2020Q4	ecor	Inventory Raw Materials Current And Noncurrent InventoryRawMaterialsCurrentAndNoncurrent	1008653	USD
CY2021Q2	ecor	Inventory Work In Process Current And Noncurrent InventoryWorkInProcessCurrentAndNoncurrent	4245931	USD
CY2020Q4	ecor	Inventory Work In Process Current And Noncurrent InventoryWorkInProcessCurrentAndNoncurrent	4304415	USD
CY2021Q2	ecor	Inventory Finished Goods Current And Noncurrent InventoryFinishedGoodsCurrentAndNoncurrent	415360	USD
CY2020Q4	ecor	Inventory Finished Goods Current And Noncurrent InventoryFinishedGoodsCurrentAndNoncurrent	428549	USD
CY2021Q2	ecor	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	5528387	USD
CY2020Q4	ecor	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	5741617	USD
CY2021Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4450569	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	4865181	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	1077818	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	876436	USD
CY2021Q2	ecor	Inventory Noncurrent Raw Materials InventoryNoncurrentRawMaterials	800000	USD
CY2020Q4	ecor	Inventory Noncurrent Raw Materials InventoryNoncurrentRawMaterials	700000	USD
CY2021Q2	ecor	Inventory Noncurrent Work In Process InventoryNoncurrentWorkInProcess	3700000	USD
CY2020Q4	ecor	Inventory Noncurrent Work In Process InventoryNoncurrentWorkInProcess	4200000	USD
CY2021Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	46942	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	87247	USD
CY2020Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	119650	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	273034	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	355923	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	163962	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	167524	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	705844	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2058757	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	592881	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1465876	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	555238	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517257	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	542695	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	534547	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	923181	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	885333	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1465876	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1419880	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M18D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2021Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.138	pure
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.138	pure
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	665504	USD
CY2021Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	200850	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	270543	USD
CY2021Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	959903	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1424878	USD
CY2021Q2	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	464009	USD
CY2020Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	371033	USD
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	540000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	751318	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	734366	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2916080	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2800820	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6552332	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6755472	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	20185	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.29
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5070536	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.47
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	78000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1885468	shares
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	216944000	USD
CY2021Q2	ecor	Warrants And Rights Outstanding Expired WarrantsAndRightsOutstandingExpired	498255	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.70
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y9M18D
CY2021Q2	ecor	Proceeds From Sale Of Net Operating Losses ProceedsFromSaleOfNetOperatingLosses	1400000	USD
CY2021Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	900000	USD
CY2020Q2	ecor	Proceeds From Sale Of Net Operating Losses ProceedsFromSaleOfNetOperatingLosses	1200000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3815585	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.56
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1275136	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.02
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	39500	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	837973	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1002758	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1780156	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1747623	USD
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5800000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.98
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.801	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.421	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure

Files In Submission

Name	View Source	Status
0001213900-21-040540-index-headers.html	Edgar Link	pending
0001213900-21-040540-index.html	Edgar Link	pending
0001213900-21-040540.txt	Edgar Link	pending
0001213900-21-040540-xbrl.zip	Edgar Link	pending
ecor-20210630.htm	Edgar Link	pending
ecor-20210630.xsd	Edgar Link	pending
ecor-20210630_cal.xml	Edgar Link	unprocessable
ecor-20210630_def.xml	Edgar Link	unprocessable
ecor-20210630_htm.xml	Edgar Link	completed
ecor-20210630_lab.xml	Edgar Link	unprocessable
ecor-20210630_pre.xml	Edgar Link	unprocessable
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ECOR
electroCore, Inc. Stock $ecor

2021 Q3 Form 10-Q Financial Statement

#000121390021040540 Filed on August 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ECOR electroCore, Inc. Stock $ecor

2021 Q3 Form 10-Q Financial Statement

#000121390021040540 Filed on August 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ECOR
electroCore, Inc. Stock $ecor